---
title: "Bio-Thera Solutions Gets Clinical Trial Approval for Breast Cancer Treatment"
date: "2025-02-11 15:29:06"
summary: "Bio-Thera Solutions received approval from China's drug administrator to conduct clinical trials for BAT1006, a monoclonal antibody targeting HER2. The drug will be tested in combination with trastuzumab and chemotherapy for treating breast cancer, according to a Tuesday filing with the Shanghai bourse. Shares of the biotechnology company were down..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Bio-Thera Solutions received approval from China's drug administrator to conduct clinical trials for BAT1006, a monoclonal antibody targeting HER2.

The drug will be tested in combination with trastuzumab and chemotherapy for treating breast cancer, according to a Tuesday filing with the Shanghai bourse.

Shares of the biotechnology company were down 1% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:G2466161:0/)
